The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
In a move reflecting the trend of semiconductor giants optimizing their software portfolios, Applied Materials has completed the divestiture of its manufacturing intelligence platform. TELEO Capital Management acquired the SmartFactory Rx platform, which specializes in pharmaceutical manufacturing. Following the acquisition, the platform has been rebranded as Modersys and will operate as an independent entity focused on the life sciences sector.
This transaction occurs as Applied Materials streamlines its operations to focus on core semiconductor equipment, while private equity firms like TELEO expand into AI-driven solutions for critical industries. Compared to industry peers, companies such as ASML and Lam Research are increasingly prioritizing digital supply chain efficiency per market data. Modersys now enters the market as a standalone player in real-time analytics for the biopharmaceutical sector, a field seeing rapid adoption of automation technologies.
Sign in to access this content
Sign InInvestors should monitor AMAT stock, which closed at $640.18 on June 22, 2026, after reaching a daily high of $641.18. On the macro front, the market continues to digest the Fed Interest Rate Decision from June 17, 2026, which held rates at 3.75%, as these levels influence the financing landscape for future technology acquisitions and sector valuations.